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transmission of meticillin-resistant Staphylococcus aureus: 
a genomic epidemiology analysis
Francesc Coll*, Kathy E Raven*, Gwenan M Knight*, Beth Blane, Ewan M Harrison, Danielle Leek, David A Enoch, Nicholas M Brown, 
Julian Parkhill, Sharon J Peacock 
Summary
Background Whole-genome sequencing (WGS) can be used in genomic epidemiology investigations to confirm or 
refute outbreaks of bacterial pathogens, and to support targeted and efficient infection control interventions. We 
aimed to define a genetic relatedness cutoff, quantified as a number of single-nucleotide polymorphisms (SNP), for 
meticillin-resistant Staphylococcus aureus (MRSA), above which recent (ie, within 6 months) patient-to-patient 
transmission could be ruled out.
Methods We did a retrospective genomic and epidemiological analysis of MRSA data from two prospective 
observational cohort studies in the UK to establish SNP cutoffs for genetic relatedness, above which recent 
transmission was unlikely. We used three separate approaches to calculate these thresholds. First, we applied a linear 
mixed model to estimate the S aureus substitution rate and 95th percentile within-host diversity in a cohort in which 
multiple isolates were sequenced per individual. Second, we applied a simulated transmission model to this same 
genomic dataset. Finally, in a second cohort, we determined the genetic distance (ie, the number of SNPs) that would 
capture 95% of epidemiologically linked cases. We applied the three approaches to both whole-genome and 
core-genome sequences.
Findings In the linear mixed model, the estimated substitution rate was roughly 5 whole-genome SNPs (wgSNPs) 
or 3 core-genome SNPs (cgSNPs) per genome per year, and the 95th percentile within-host diversity was 19 wgSNPs 
or 10 cgSNPs. The combined SNP cutoffs for detection of MRSA transmission within 6 months per this model were 
thus 24 wgSNPs or 13 cgSNPs. The simulated transmission model suggested that cutoffs of 17 wgSNPs or 12 cgSNPs 
would detect 95% of MRSA transmission events within the same timeframe. Finally, in the second cohort, cutoffs 
of 22 wgSNPs or 11 cgSNPs captured 95% of epidemiologically linked cases within 6 months.
Interpretation On the basis of our results, we propose conservative cutoffs of 25 wgSNPs or 15 cgSNPS above which 
transmission of MRSA within the previous 6 months can be ruled out. These cutoffs could potentially be used as part 
of a genomic sequencing approach to the management of outbreaks of MRSA in conjunction with traditional 
epidemiological techniques.
Funding UK Department of Health, Wellcome Trust, UK National Institute for Health Research.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
The potential benefits of using bacterial-sequencing 
techniques in routine clinical practice has been well 
documented in the past 10 years. One of the 
first applications of this technology in a clinical context 
was the use of a benchtop sequencer to retro spectively in-
vesti gate an outbreak of meticillin-resistant Staphylococcus 
aureus (MRSA) in a neonatal intensive-care unit.1 The data 
generated could distinguish MRSA iso lates (and patients) 
involved in the outbreak from those that were not.1 A 
subsequent investigation2 of an MRSA outbreak in a 
special care baby unit showed that standard practice 
augmented by sequencing was superior to standard 
practice alone (in terms of identifying cases that would 
otherwise have been missed), and resulted in an inter-
vention that brought the outbreak to a close. Sequencing 
can be used to rule out the possibility of an outbreak when 
MRSA-positive patients are clustered by chance,3 thereby 
reducing unnecessary investigation and interventions. 
Prospective sequencing can also detect far more outbreaks 
than standard infection control surveillance: a genomic 
surveillance study4 of MRSA isolated in a clinical micro-
biology laboratory in the east of England over 12 months 
identified 173 separate transmission clusters (cluster sizes 
ranged from two to 44 cases) involving 598 people, none of 
which were detected by conventional infection control 
approaches.
Although the translation of bacterial sequencing has 
clear benefits for effective infection control practice, 
cost, automation of sample preparation, easy-to-use 
genome interpretation tools, and lack of standards for 
genome analyses and interpretation are barriers to the 
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successful adoption of this technology. A major issue is 
the lack of evidence for a genetic relatedness cutoff 
between MRSA isolates that is consistent with recent 
transmission (ie, within the past 6 months). Definition 
of such a cutoff is essential to enable consistent 
decisions to be made by personnel who do not have 
bioinformatics expertise. A genetic related ness cutoff 
would also support rapid triaging of routine prospective 
bacterial sequence data before epidemio logical data are 
available. These sequencing data could thus function as 
an early-warning system of related bac terial isolates 
and could lead to highly targeted investi gation and 
intervention to prevent further spread.
The simplest way to establish genetic relatedness bet-
ween bacterial isolates is to count the number of individual 
nucleotides that differ—ie, the number of single-nucleo-
tide polymorphisms (SNPs)—between their whole or core 
genome sequences. The SNP cutoff approach places 
two individuals in the same putative transmission cluster 
if the genetic relatedness of their bacterial isolates is below 
a pre-defined number of SNPs. In this study, we aimed to 
define a SNP cutoff between any two MRSA isolates by 
applying three methods to two large MRSA datasets inc-
luding clinical evaluations. We also sought to derive a SNP 
cutoff based on a core genome that could be applied in any 
setting irrespective of the dominant S aureus or MRSA 
lineages.
Methods
Patient cohorts and epidemiological data
We did a retrospective genomic analysis of MRSA data 
from two prospective observational cohort studies in 
the UK. Recruitment, MRSA sampling, and selection 
criteria for whole-genome sequencing (WGS) for the two 
cohort studies are described in detail in appendix 1 
(pp 12–14). The first cohort study4 (cohort 1) was done 
between April 12, 2012, and April 11, 2013, and the second5 
(cohort 2) was done between Jan 24 and Nov 1, 2018. The 
aim of both studies was to identify consecutive individuals 
with MRSA-positive samples processed by the Clinical 
Microbiology and Public Health Laboratory at the 
Cambridge University Hospitals NHS Foundation Trust 
(Cambridge, UK). The studies were approved by the 
National Research Ethics Service (reference 11/EE/0499), 
the National Information Governance Board Ethics and 
Confidentiality Committee (reference ECC 8-05(h)/2011), 
and the Cambridge University Hospitals NHS Foundation 
Trust Research and Development Department (refe-
rence A092428). The studies were observational and 
laboratory-based, and all samples were anonymous and 
collected as part of routine clinical care. Thus the require-
ment for patient consent was waived. 
Epidemiological data (sample date, sampling location, 
hospital admission and ward movement data, general 
practitioner registration, and residential postcode) were 
See Online for appendix 1
Research in context
Evidence before this study
We searched PubMed with the terms “whole genome 
sequencing”, “MRSA”, “transmission” AND “hospital” for 
original research articles published in English 
up to March 31, 2020, in which whole-genome sequencing had 
been applied to study transmission of meticillin-resistant 
Staphylococcus aureus (MRSA) in human populations in hospital 
settings. Of the 35 studies that we identified, WGS was done 
retrospectively in 17—mostly in the context of suspected 
outbreaks. Investigators used genetic relatedness thresholds 
to confirm or refute recent transmission in only five of these 
studies. Rather, WGS was used to confirm the clonality and 
small genetic distances expected between isolates of the 
same outbreak. In 11 of the 18 prospective studies we 
identified, investigators used relatedness thresholds to exclude 
recent transmission of MRSA. Two common approaches have 
been used to define such thresholds: the maximum number 
of single-nucleotide polymorphisms (SNPs) observed from 
the same individual, (previously reported values include 
10, 40, 43, and 71 SNPs), or the maximum SNP distance 
between epidemiologically linked cases, with values 
of 23 and 50 SNPs reported previously (appendix 1 pp 2–3). 
In the seven prospective studies in which thresholds were not 
used, authors generally reported the number of SNPs recorded 
between epidemiologically linked cases.
Added value of this study
In this study, we propose a genetic relatedness threshold of 
25 whole-genome or 15 core-genome SNPs, above which recent 
transmission (ie, within the previous 6 months) of MRSA can be 
ruled out. Our findings were based on the genomes of MRSA 
isolates from two large patient cohorts, took into account how 
much genetic diversity would be expected to accumulate over 
time and be transmitted between individuals, were informed by 
epidemiological data, and were validated in a third independent 
dataset. The robustness of our findings was verified using three 
independent approaches. 
Implications of all the available evidence
The genetic relatedness thresholds we calculated have a 
potential role in genomic sequencing approach to management 
of outbreaks of MRSA, in which they could be used to exclude 
patients with MRSA who are unlikely to be part of the same 
outbreak and to focus on those who will require epidemiological 
follow-up. Our proposed MRSA relatedness cutoffs could also be 
adopted by academic and clinical laboratories, who are 
increasingly implementing genomic surveillance. Our approaches 
to establishing SNP relatedness cutoffs could potentially be 
applied to calculate equivalent relatedness cutoffs for other 
bacterial pathogens.
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obtained via the hospital computer system for all patients 
who tested positive for MRSA.  Potential epidemiological 
links in cohort 2 were investigated up to 6 months before 
the first sample in a pair, which was defined as an 
individual and the person whose MRSA isolates most 
closely matched their own. Ward and community 
contacts were regarded as strong epidemiological links 
whereas hospital contact was considered a weak link (on 
the basis of the findings of our previous study; appendix 1 
p 13).4 In this study we also used a previously published6 
independent collection of S aureus genomes collected in 
an intensive-care unit in Brighton, UK .
In cohort 1 and the independent external collection 
multiple isolates were sequenced for each participant 
(collected on either the same or different days), whereas 
in cohort 2 only one isolate per individual was sequenced.
Microbiology, DNA sequencing, and genomic analyses
A detailed description of MRSA isolation, bacterial DNA 
extraction, library preparation, sequencing, and gen-
omic analyses is provided in appendix 1 (pp 13–15). 
Briefly, DNA was extracted, libraries were prepared, and 
paired-end sequences were obtained on Illumina (San 
Diego, CA, USA) seq uencing machines (HiSeq2000 in 
cohort 1, MiniSeq used in cohort 2). The bioinformatic 
pipelines for de-novo assembly, multi-locus sequence 
typing from de-novo assemblies, short-read mapping, 
SNP calling, and quality control for geno mic data have 
been previously described for cohort 1.4 The same 
procedures were also applied to cohort 2 and the 
independent external collec tion. Whole-genome SNP 
(wgSNP) distances were calculated by using the entire 
EMRSA15 reference genome (accession number 
HE681097; 2·83 Mb) after extraction of mobile genetic 
elements (2·67 Mb),7 whereas core-genome SNP 
(cgSNP) distances were calculated on the basis of the 
portion of the reference genome that corresponded to 
the species core genome.8 We used a genetically and geo-
graphically diverse collec tion of 800 S aureus isolates9 to 
derive the species core genome, which consisted of 
1766 genes and covered 1·76 Mb (62%) of the reference 
genome. Isolates from all cohorts were also mapped to 
ST30 strain MRSA252 (accession number BX571856) to 
test the effect of using a different reference genome in 
SNP cutoff calculations.10,11 
Procedures
A genetic relatedness cutoff for detection of MRSA 
transmission was derived by applying three approaches 
to two different MRSA cohorts. First, we used data from 
cohort 1 to calculate a theoretical SNP cutoff informed by 
the S aureus substitution rate and within-host diversity 
(approach A; figure 1A). Second, a simulation model, 
parameterised with the same data, was used to estimate 
SNP distances between simulated transmission pairs 
(approach B; figure 1A). The agreement between these 
two independent methods in cohort 1 was used to assess 
their methodological robustness. Third, the distribution 
of SNP distances among epidemiologically linked cases 
was derived from cohort 2 (approach C; figure 1A). 
Finally, we used the independent external collection of 
genomes to assess the generalisability (ie, in a different 
geographical location with different S aureus strains) of 
the SNP cutoff (figure 1B).
Before applying approach A, we calculated SNP and time 
distances between pairs of isolates from the same 
individual (appendix 2) for coh ort 1. Outliers—pairs of 
isolates representing inde pen dent (mixed) strains—were 
filtered out from further analyses. We used the calculated 
SNP and time distances to estimate the amount of pre-
existing diversity (ie, the cloud of diversity) and the 
substitution rate. We calculated an empirical cloud of 
diversity in people from whom more than one MRSA 
isolate was collected on the same day. For each individual, 
we calculated the maximum pairwise SNP distance 
between their isolates, and used the 95th percentile across 
all individuals. We also applied a linear mixed regression 
model (LMM) to the data, in which the SNP distance was 
treated as the dependent variable and time distance as the 
independent variable (fixed effect). The intercept was 
interpreted as the amount of pre-existing diversity (which 
we refer to as modelled cloud of diversity) and was allowed 
to vary by individual (random effect), as we observed that 
the empirical cloud of diversity varied by individual 
(pre sumably as a result of different duration of colonisation 
and other factors). We interpreted the slope of the fixed 
effect as the substitution rate (appendix 1 pp 15–16). 
Because individuals had a different number of isolate 
genomes available per sampling date, they were 
de-duplicated by random subsampling to retain only one 
isolate per person per date. The reported substitution rates 
and modelled cloud of diversity are the median values 
resulting from sub-sampling and running the 
LMM 100 times. The substitution rate per site per year was 
calculated for the core genome by dividing the average 
substitution rate of the core genome by the length of the 
core genome. The LMM was run with the lmer function in 
the R package lme4 (version 1.1–23). Plots were created in 
ggplot2 (version 3.3.1).
In approach A, we assumed that the genetic distance 
between any two MRSA isolates obtained from different 
individuals during an outbreak would be dictated by the 
amount of pre-existing diversity that could be transmitted 
from the source, plus the number of SNPs that could 
accumulate over time in the source and recipient hosts. 
We used the estimated values of the cloud of diversity 
and substitution rate to derive a SNP cutoff to detect 
MRSA transmission within 6 months (a frequently used 
timeframe in infection control investigations) with the 
following formula: SNP cutoff=(95th percentile of the 
initial cloud of diversity) + (expected mutation accumu-
lation over 6 months × 2). We used the 95th percentile 
rather than the maximum cloud of diversity observed to 
avoid including extreme values at the upper end of the 
See Online for appendix 2
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Figure 1: Overview of study 
design, patient cohorts, and 
methods
(A) Approaches used to 
calculate a SNP cutoff above 
which MRSA transmission 
within a 6-month period is 
unlikely (appendix 1 
pp 15–18). In approach A, 
a linear mixed model was used 
to calculate the cloud of 
diversity and substitution rate 
for MRSA; these parameters 
informed the estimation of 
the SNP cutoff. In approach B, 
exponential distributions of 
SNP distances in source and 
recipient patients were 
sampled in a simulation model 
(run 200 000 times) to 
estimate the SNP cutoff. In 
approach C, genomic and 
epidemiological data were 
integrated to derive the SNP 
cutoff. (B) Overview and 
relationships of all approaches 





type. T0=timespan 0. 
T1=timespan 1. Tx=generic 
timespan. 
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exponential distribution. Expected mutation accumu-
lation over 6 months was doubled to account for the fact 
that after a transmission event, the MRSA genomes in 
the source and recipient would accumulate SNPs in 
different positions in the genome.
The simulation model in approach B was based on 
data from cohort 1 (appendix 1 pp 16–18). Distributions 
of SNP distances were generated for source and recipient 
patients within 6 months of a transmission event. For 
the source patient, exponential distributions were fitted 
to the data for within-host SNP distances bet ween 
isolates sampled on different dates (appendix 1 pp 10–11). 
From these distributions, we built a gen eralised 
exponential distribution of SNP distances by time 
between sampling to simulate within-host variation 
between transmission and subsequent time of sampling. 
For the recipient patient (who was assumed not to be 
colonised with MRSA at the time of transmission before 
being colonised by a single strain, so-called transmission 
bottleneck), the fitted mutation rate from the LMM 
provided a mean for an exponential distribution of 
poten tial SNP distances at any given time. To this SNP 
distance, we added the SNP distance between the trans-
mitted isolate and the isolates remaining in the source 
patient, the latter of which was randomly sampled from 
the distribution of within-host SNP distances between 
isolates taken on the same day. The simulation model 
assumed a cohort of 445 transmission pairs (to match 
cohort 1) and sampled the generalised exponential 
distributions to give SNP distances from the transmitted 
isolate in both the source and recipient patients, which 
were then summed to give a SNP distance. We calculated 
the SNP distance threshold that would capture 95% of 
the transmission events. This process was repeated 
200 000 times, and the maximum value and range of this 
threshold over 10 sets of 200 000 runs was used as the 
simulation model output.
In approach C, we paired each patient in cohort 2 with 
the individual whose MRSA isolate was the closest 
genetic match (allowing a maximum genetic distance of 
50 SNPs between isolates) and defined the epidemio-
logical contact of each pair as weak, strong, or no contact. 
If a patient had a strong epidemiological link to the 
person whose MRSA isolate was the closest genetic 
match to their own, they were defined as epidemiologically 
linked cases. Approaches A, B, and C were all imple-
mented in R (version 3.6.3).
We used the external independent dataset of S aureus 
genomes (appendix 3) to assess the generalisability of the 
SNP cutoff. We derived a SNP cutoff by applying approach 
A to the external dataset as we did for cohort 1. We then 
did two subset analyses (also with approach A): one to 
assess whether the SNP cutoff was affected by the 
sequence type (ST) of the reference genome used (ST22 or 
ST30), and another to assess the effect of using S aureus 
isolates from patients with clinically confirmed MRSA 
infections or from patients who were asymptomatically 
colonised (because S aureus intra-host diversification can 
differ between infect ion and colonising sites12,13).
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the Article. All authors had full access to all the 
data in the study and had final responsibility for the 
decision to submit for publication.
Results
Cohort 1 consisted of 1465 people with at least one 
MRSA-positive sample as reported previously (total 
sample 2282 MRSA isolates).4 In 1006 (69%) people, 
only one isolate was sequenced. We restricted our 
analysis to the remaining 459 (31%) people, from whom 
1276 MRSA isolates were sequenced (median 2 
[range 2–15; IQR 2–3] per patient). The frequency of 
clonal complexes is detailed in appendix 1 (p 3). 
Cohort 2 comprised 778 people with at least one MRSA-
positive sample. Most patients (n=775 [100%]) provided 
one MRSA isolate. Overall, 781 isolates were cultured 
from multisite screens (526 [67%] from typical 
colonising sites) or diagnostic specimens (255 [33%] 
from infection sites) and sequenced. In our analysis, 
we focused on a subset of 429 (55%) individuals who 
were positive for an MRSA strain that was within 
50 wgSNPs of the MRSA carried by at least one other 
patient, because recent transmission beyond this gen-
etic distance is very unlikely (appendix 1 pp 2–3).4
Of the 459 patients with multiple MRSA isolates in 
cohort 1, 14 (3%) were infected with independent (mixed) 
strains, and a further nine (2%) patients were infected 
with both the same and independent strains. We removed 
these outliers and kept the remaining isolate pairwise 
com parisons from the same patient and strain (1510 isolate 
pairs from 445 patients; appendix 2). When these data 
were inputted into the LMM, the average substitution rate 
per genome per year was 4·70 wgSNPs (95% CI 
2·85–6·54) or 2·92 cgSNPs (1·69–4·15). The substitution 
rate per site per year of the core genome was 1·66 × 10–⁶ 
(95% CI 9·63 × 10–⁷–2·36 × 10–⁶), which was similar to that 
esti mated for the whole genome without mobile genetic 
ele ments (1·76 × 10–⁶ [95% CI 1·07 × 10–⁶–2·45 × 10–⁶]). 
Substitution rates were similar irrespective of the 
reference genome (ST22 or ST30) and portion of the 
genome used for calling SNPs (whole or core genome; 
appendix 1 p 4). The 95% CIs for our estimates overlap 
with S aureus substitution rates estimated in other studies 
(appendix 1 p 4).14–21 Both the empirical and modelled cloud 
of diversity followed the same exponential distribution 
(figure 2). We chose the 95th per centile value from the 
modelled distribution (19 wgSNPs or 10 cgSNPs; 
n=445 patients) rather than that from the empirical distri-
bution (14 wgSNPs or 10 cgSNPs; n=82 individuals) 
because the former was based on more patients and was 
thus likely to be more accurate.
See Online for appendix 3
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In approach A, we added the 95th percentile values 
from the modelled cloud of diversity distribution 
(ie, 19 wgSNPs or 10 cgSNPs) to the number of SNPs 
expected to accumulate over 6 months in the source and 
recipient hosts (4·70 wgSNPs or 2·92 cgSNPs, rounded 
to 5 or 3, respectively) to estimate a SNP cutoff for 
detecting MRSA transmission within the previous 
6 months of 24 wgSNPs or 13 cgSNPs (table).
In approach B, according to our simulation model of 
pairwise MRSA transmission based on the 445 included 
patients from cohort 1 and run 200 000 times, a maximum 
of 17 wgSNPs (range 16–17) or 12 cgSNPs (11–12) were 
needed to capture 95% of transmission events occurring 
within a period of 6 months.
In approach C, in which we studied SNP distances 
among epidemiologically linked cases in cohort 2 
(appendix 4), we observed a decline in the number of 
strong epidemiological links with increasing SNP dis-
tances in both the whole and core genome (figure 3A, 3B). 
Of the 429 individuals who were positive for an MRSA 
strain with a genetic distance of 50 wgSNPs or less from 
the MRSA carried by at least one other patient, 294 (69%) 
had available epidemiological data and 98 (23%) had 
strong epidemiological links. When we plotted the 
distri bution of SNP distances for these 98 individuals, 
22 wgSNPs (figure 3C) or 11 cgSNPs (figure 3D) cap-
tured 95% of epidemiologically linked cases. We 
repeated this analysis for the subset of indivi duals with 
strong hospital links (ie, people who, within a 6-month 
period, had been on the same hospital ward within 
1 week of each other) and found that 22 wgSNPs or 
7 cgSNPs cap tured 95% of putative noso comial trans-
mission (appendix 1 pp 7–8). SNP dis tances were higher 
between individuals with com munity epidemio logical 
links (appendix 1 pp 7–8).
We also derived a SNP cutoff for detection of recent 
MRSA transmission based on an independent collection 
of S aureus genomes from a different setting,6 which 
mostly consisted of meticillin-susceptible strains and had a 
different proportions of clonal complexes from those of 
cohorts 1 and 2 (appendix 1 p 3). 11 167 isolate pairwise 
comparisons from 255 individuals (appendix 3) were used. 
The 95th percentile of the empirical cloud of diversity 
(n=146 individuals) in this dataset was 21 wgSNPs or 
11 cgSNPs (appendix 1 p 9) and the annual substitution 
rate was 4·90 wgSNPs (appendix 1 p 4), which would result 
in a theoretical SNP cutoff (per app roach A) of 26 wgSNPs 
or 14 cgSNPs—similar to but slightly higher than those 
calculated based on cohort 1. Our subset analyses showed 
that the SNP cutoff was unaffected by the sequence type of 
the reference genome used (appendix 1 p 5) and that 
SNP cutoffs for isolates collected from infection sites were 
slightly lower (21 wgSNPs and 11 cgSNPs) than those 
collected from people asymptomatically colonised with 
MRSA (25 wgSNPs and 14 cgSNPs; appendix 1 p 6).
Discussion
Genome sequencing of bacterial pathogens has emerged 
as the new gold standard technology for the detection of 
transmission and outbreaks in health-care settings.6,22,23 
Genetic relatedness thresholds that define the genetic 
distance expected between recently transmitted bacteria 
would facilitate the interpretation of genome sequencing 
data and enable infection control teams to focus their 
attention on patients with greater probability of being 
part of an outbreak.24 In this genomic epidemiological 
analysis, we used three different app roaches in two patient 
cohorts asymptomatically colo nised or infected with 
Figure 2: Empirical (A) and modelled (B) clouds of MRSA genetic diversity across individuals in the whole 
genome and empirical (C) and modelled (D) clouds of MRSA genetic diversity across individuals in the core 
genome
Each datapoint corresponds to the maximum pairwise genetic distance between MRSA isolates from the same 
individual in cohort 1, measured as the number of SNPs in the whole or genome. The empirical cloud of diversity 
refers to diversity noted between isolates from the same individual collected on the same day. The modelled cloud 
of diversity was estimated from a linear mixed model of isolates from the same individual collected on different 
days. MRSA=meticillin-resistant Staphylococcus aureus. SNP=single-nucleotide polymorphism.




















95th percentile: 14 SNPs
95th percentile: 10 SNPs
95th percentile: 19 SNPs
95th percentile: 10 SNPs
SNP cutoff*
Whole genome
Approach A (cohort 1) 24
Approach B (cohort 1) 17 (16–17)†
Approach C (cohort 2) 22
Core genome
Approach A (cohort 1) 13
Approach B (cohort 1) 12 (11–12)†
Approach C (cohort 2) 11
SNP=single-nucleotide polymorphism. *Within a period of 6 months. †Maximum 
(range) over ten sets of 200 000 simulations.
Table: SNP cutoffs estimated by different approaches in the whole 
genome or in the core genome
See Online for appendix 4
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MRSA to establish an SNP cutoff for detection of recent 
trans mission. We calculated cutoffs that ranged from 17 to 
24 wgSNPs, or from 11 to 13 cgSNPs. On the basis of 
these findings, we propose a conservative cutoff of 
25 wgSNPs or 15 cgSNPs, above which 95% of recent 
MRSA transmission events can be ruled out within a 
period of 6 months.
Cohorts spanning longer periods will be needed to 
establish SNP cutoffs to detect transmission beyond 
6 months. Other cutoffs informed by the maximum gen-
etic distance observed within individuals (eg, 40 SNPs)6 
or maximum distance between epidemiol ogically linked 
cases (eg, 50 SNPs)4 have been reported in the literature 
(appendix 1 pp 2–3) and are likely to capture older trans-
mission events (of several years) that are beyond the 
timeframe infection prevention and control teams would 
be investigating. In our study, we noted higher SNP 
distances bet ween isolates from individuals with 
community epidemio logical links, than between those 
from individuals with strong hospital epidemiological 
links. This obser vation suggests older transmission 
events (ie, older than 6 months) were being captured, 
and that a higher SNP cut off might thus be needed to 
capture S aureus trans mission outside hospitals.
We calculated SNP cutoffs for the core genome as well 
as the whole genome. The advantage of using the core 
genome is that the chromosome length and content 
being used to call SNPs will be the same irrespective of 
the reference genome used and sequence types being 
compared, and thus the cgSNP cutoff could be used in 
any setting regardless of the dominant S aureus or MRSA 
lineages. Although we acknowledge that a core-genome 
approach will never capture as many SNPs as aligning 
the whole genomes of isolates to each other or to a closer 
reference genome, our findings suggest that there was 
sufficient variability in the core genome to capture 
substitutions rates and within-host diversity, and thus to 
derive a cgSNP cutoff.
Our methods could be used to define SNP cutoffs for 
other bacterial pathogens. For more recombinogenic 
bacteria, as long as genome analysis pipelines can detect 
and remove recombination, the presence of homologous 
recombination should not be an obstacle to derivation of 
similar SNP cutoffs that are based on the accumulation 
of point mutations.
A SNP cutoff is a simple and intuitive measure of 
genetic relatedness and could be easily incorporated into 
automated genome analysis tools and interpreted by 
non-expert users in a clinical setting. A limitation of this 
approach is that the likelihood of direct transmission 
below the cutoff cannot be inferred. The identification of 
common epidemiological links (such as visits to the 
same hospital ward, unit, or clinic, shared residential 
postcodes, or management by the same health-care 
worker) is still essential to confirm definite transmission. 
However, the SNP cutoff would reduce the number of 
patients who require detailed epidemiological follow-up. 
In cohort 2, for example, use of the 25 wgSNPs cutoff 
would mean that only 368 (48%) of the 775 MRSA-
positive patients would need to be followed up. Savings 
associated with using our approach compared with 
universal epidemiological investigation of all MRSA 
cases might vary depending on local MRSA epidemiology. 
Another limitation is that SNP cutoffs cannot be used to 
identify the source and recipient of individual trans-
mission events (direc tionality), to establish the probability 
of transmission, or to characterise the overall trans-
mission dynamics of an outbreak. Alternative phylo-
genetic and probabilistic approaches have been proposed 
for such questions.25–28
In conclusion, our study provides evidence for a SNP 
cutoff for MRSA, and describes an approach that can be 
applied to define SNP cutoffs for other bacterial pathogens 
as similar large sequencing datasets become available. 
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Figure 3: Distribution of SNP distances among epidemiologically linked individuals
Number of individuals who had a MRSA isolate genetically linked to that of another individual in cohort 2, grouped 
by increasing whole-genome (A) or core-genome (B) SNP distances, and colour-coded by the strength of 
epidemiologically link between them (n=294). (C) and (D) show the subset of patients with strong epidemiological 
links (n=98). MRSA=meticillin-resistant Staphylococcus aureus. SNP=single-nucleotide polymorphism.
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Data sharing
The whole-genome sequences from this study have been deposited 
at European Nucleotide Archive (study accessions PRJEB3174 and 
PRJEB32286). Individual accession numbers are listed in 
appendices 2–4. The R code implementing approach A and B 
(snp-cutoff.within_host_diversity.R) and approach C (snp-cutoff.
between_hosts_links.R) are available on GitHub.
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